L. Stover

Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy.

J. Kirkwood, S. Agarwala, S. Donnelly, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of Gemcitabine and 2′,2′‐Difluorodeoxyuridine in a Patient with Ascites

W. Plunkett, W. Plunkett, E. Zuhowski, 2000, Pharmacotherapy.

Managing toxicities of high-dose interleukin-2.

J. Dutcher, R. Schwartz, L. Stover, 2002, Oncology.

Phase II trial of high-dose bolus (HDB) IL-2 in patients with metastatic melanoma (MM) who haveprogressed after biochemotherapy (BCT): Updated results

J. Kirkwood, W. Gooding, S. Agarwala, 2005 .